收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 311.42M | -1.51% |
| Gross profit | profit | 208.29M | -2.92% |
| Cost of sales | cost | 103.13M | 1.48% |
| Operating income | profit | 75.50M | 95.04% |
| Operating expenses | cost | 132.79M | -24.48% |
| Income (loss) from continuing operations before income taxes, noncontrolling interest | profit | 71.22M | 86.09% |
| Other income (expense) | revenue | 4.27M | 883.87% |
| Net earnings | profit | 51.05M | 125.99% |
| Income taxes | cost | 20.18M | 28.64% |
| Comprehensive income (loss), net of tax, attributable to parent | profit | 46.53M | 77.71% |
| Other comprehensive income (loss), net of tax | profit | 4.51M | 25.40% |
| Foreign currency translation income (loss) | revenue | 4.35M | -1.82% |
| Unrealized gains (losses) on derivative instruments | revenue | 160000 | 0.91% |
| Segment | Value | YoY |
|---|---|---|
| Protein Sciences | 226.15M | -0.67% |
| Diagnostics and Spatial Biology | 85.59M | -4.08% |
| Segment | Value | YoY |
|---|---|---|
| UNITED STATES | 167.48M | -7.94% |
| EMEA, excluding UK | 73.45M | 10.44% |
| CHINA | 26.01M | 6.25% |
| APAC, excluding Greater China | 21.82M | 2.71% |
| UNITED KINGDOM | 14.89M | 15.87% |
| Rest of World | 7.77M | -15.38% |
| Segment | Value | YoY |
|---|---|---|
| Product and Services | 306.45M | -1.51% |
| Consumables | 257.34M | -0.17% |
| Instruments | 27.66M | 5.95% |
| Service | 21.45M | -21.29% |
| Royalty | 4.97M | -1.43% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable, less allowances of $4,415 and $4,215, respectively | assets | 214.56M | |
| Cash and cash equivalents | assets | 209.82M | |
| Inventories | assets | 201.18M | |
| Other current assets | assets | 62.49M | |
| Assets, current | assets | 688.05M | |
| Goodwill | assets | 977.80M | |
| Intangible assets, net | assets | 319.07M | |
| Other assets, noncurrent | assets | 264.37M | |
| Property and equipment, net | assets | 232.99M | |
| Operating lease rou assets | assets | 68.32M | |
| Assets | assets | 2.55B | |
| Long-term debt obligations | liabilities | 200.00M | |
| Liabilities, current | liabilities | 153.28M | |
| Operating lease liabilities - long-term | liabilities | 76.14M | |
| Other long-term liabilities | liabilities | 21.67M | |
| Deferred income taxes | liabilities | 14.21M | |
| Equity, attributable to parent | equity | 2.09B | |
| Accumulated other comprehensive loss | liabilities | 66.86M | |
| Salaries, wages and related accruals | liabilities | 54.43M | |
| Contract liabilities | liabilities | 38.43M | |
| Trade accounts payable | liabilities | 23.49M | |
| Accrued expenses | liabilities | 17.68M | |
| Operating lease, liability, current | liabilities | 14.18M | |
| Income taxes payable | liabilities | 2.97M | |
| Other current liabilities | liabilities | 2.09M | |
| Aggregate | equity | 2.15B | |
| Retained earnings (accumulated deficit) | liabilities | 1.15B | |
| Additional paid-in capital | liabilities | 1.01B | |
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,516,091 and 154,972,196 respectively | liabilities | 1.56M |
| Item | Value |
|---|---|
| Net income (loss), including portion attributable to noncontrolling interest | 127.24M |
| Depreciation and amortization | 73.22M |
| Share-based payment arrangement, noncash expense | 36.13M |
| Deferred income taxes and tax credits | 8.04M |
| Asset impairment restructuring | 3.25M |
| Increase (decrease) in prepaid expense | 2.50M |
| Unrealized gain (loss) on investments | 2.33M |
| Other operating activity | 621000 |
| Equity method investment, realized gain (loss) on disposal | 335000 |
| Leases, net | -2.62M |
| Trade accounts payable, accrued expenses, contract liabilities, and other | -2.95M |
| Recovery of assets held-for-sale | -6.79M |
| Increase (decrease) in accounts and other receivables | -7.92M |
| Increase (decrease) in employee related liabilities | -11.20M |
| Increase (decrease) in inventories | -12.51M |
| Increase (decrease) in income taxes payable | -13.04M |
| Item | Value |
|---|---|
| Distributions from wilson wolf | 4.62M |
| Proceeds from sale of assets held-for-sale | 4.62M |
| Payments to acquire property, plant, and equipment | -20.37M |
| Item | Value |
|---|---|
| Proceeds from stock option exercises | 58.19M |
| Payments for repurchase of common stock | -24000 |
| Payment, tax withholding, share-based payment arrangement | -10.64M |
| Payments of ordinary dividends, common stock | -37.43M |
| Repayments of lines of credit | -146.00M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 162.19M |
| Cash and cash equivalents, end of period | 209.82M |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图，与现金流量表瀑布图，一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持